AGMB
AgomAb Therapeutics NV American Depositary SharesNASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$566.35M
P/E Ratio
—
EPS
$-1.49
Beta
—
52W High
$17.45
52W Low
$9.00
50-Day MA
$11.41
200-Day MA
$12.62
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
—
PEG Ratio
—
About AgomAb Therapeutics NV American Depositary Shares
AgomAb Therapeutics NV, a clinical-stage biopharmaceutical company, develops novel disease-modifying therapies for immunology and inflammatory diseases with a focus on chronic fibrotic indications with unmet medical needs. The company is headquartered in Antwerp, Belgium.
Fundamentals
| Revenue (TTM) | 0 |
| Gross Profit (TTM) | 0 |
| EBITDA | $-58.87M |
| Operating Margin | 0.00% |
| Return on Equity | -39.20% |
| Return on Assets | -20.60% |
| Revenue/Share (TTM) | $0.00 |
| Book Value | $-3.98 |
| Price-to-Book | 3.73 |
| Price-to-Sales (TTM) | — |
| EV/Revenue | - |
| EV/EBITDA | — |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 0.00% |
| Shares Outstanding | $49.25M |
| Float | $16.41M |
| % Insiders | 5.89% |
| % Institutions | 48.35% |
Historical Volatility
HV 10-Day
56.36%
HV 20-Day
66.37%
HV 30-Day
59.91%
HV 60-Day
81.66%
HV Rank
—
Volatility is currently contracting
Analyst Ratings
Consensus ($32.00 target)
2
Strong Buy1
BuyMore HEALTHCARE Stocks
Data last updated: 5/25/2026